Biotech Distilled
133 companies · 839 active programs
Substack ↗
Subscribe
Therapeutic Areas
Modalities
Phases
Targets
Companies
Home
›
Targets
› MEK 2
MEK 2
(1 companies · 2 programs)
Companies with an active program directed at MEK 2.
Pasithea Therapeutics Corp.
KTTA
PAS-004
— Neurofibromatosis Type 1
Preclinical
PAS-004
Phase 1